Currently set to Index
Currently set to No Follow

World’s First Covid-19 Vaccine Developed in Russia?

The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market


1062
Share via
219 shares, 1062 points
Share via

First Covid-19 Vaccine

 

 

Watch the video report

  • Russia has become the first nation to complete clinical trials of Covid-19 vaccine on humans
  • According to the reports, the vaccine has proven the medication’s effectiveness
  • There was, however, no further information on when this vaccine would enter the commercial production stage
  • WHO says that there are at least 21 vaccines currently under key trials around the world.

 

 


 

 

Russia announced today that they have completed the world’s first Covid-19 vaccine. According to Sechenov First Moscow State Medical University based in Russia, they have completed all clinical trials and awaiting for mass production and distribution.

Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology confirmed the information via Sputnik News. The report highlighted that all clinical trials of COVID-19 vaccine produced by Gamalei Institute of Epidemiology and Microbiology which started on June 18 has been successful.

 

 

Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University, said that the main objective of this stage of the study was to show the vaccine’s safety for human health, which was successfully done.

“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” Lukashev told Sputnik.

Russia state-run news agency TASS reported that “Gamalei center’s head Alexander Gintsburg hopes the vaccine will ‘enter civil circulation’ on Aug. 12-14. He added that he hopes private companies would begin mass production by September.”

Read more  7 Things to Consider When Buying a Gaming PC

 

 


 

 

Times of Moscow quoted Ginstsburg “The Russian Health Ministry will make a decision on the substance effectiveness based on the results of” biochemical tests, the university said in a July 3 press release.

According to Forbes, “Russia had allowed clinical trials of two forms of a potential coronavirus vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology. The first one was carried out at the Burdenko Military Hospital. The other vaccine was given to test patients at the Sechenov First Moscow State Medical University.” There were 20 people who received the vaccine shot and these volunteers were asked to quarantine in the hospital for 28 days.

 

 


 

 

Financial Express, also reported that “both groups of volunteers for clinical trials will be discharged soon. The first group will be permitted to leave in two-three days and the second group will be discharged on July 20. Citing Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical, and Vector-Borne Diseases at Sechenov University, the report mentioned that the study has been done to check vaccine’s safety when given to humans and that has now been successfully done.”

Russia plans to produce 30 million doses of an experimental COVID-19 vaccine domestically this year, with the potential to manufacture a further 170 million abroad, the head of the country’s sovereign wealth fund told Reuters.

 

Above video credit: courtesy of Arirang News, South Korea’s largest news agency

Here’s the complete list of pharmaceutical companies who are developing vaccines and treatment to fight novel coronavirus Covid-19.

Complete List of Companies Developing a Coronavirus Vaccine & Treatment

World’s First Phase 3 Clinical Trial of COVID-19 Inactivated Vaccine Starts in UAE

MIT & Harvard Strategy to Limit the Spread of COVID-19

Share via

Read more  How to Apply for Government Financial Assistance for SMEs

Like it? Share with your friends!

1062
Share via
219 shares, 1062 points
GN News Story

0 Comments

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend